Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: Germany Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20171
20182
20191
20201
20211
20221
20235
20247
202512
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intuitive Surgical3
Merck Sharp & Dohme LLC3
Pfizer3
Revolution Medicines, Inc.3
BioNTech SE2
Bristol-Myers Squibb2
Eli Lilly and Company2
Medical University of Vienna2
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms41
Carcinoma, Non-Small-Cell Lung24
Carcinoma7
Neoplasms7
Breast Neoplasms6
Colorectal Neoplasms6
Lung Diseases6
Neoplasm Metastasis6
Ovarian Neoplasms5
Small Cell Lung Carcinoma5

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.